№3/2017
Volume 10 Issue 3
|
NOVEL DRUGS |
|
| Ibrutinib in the Treatment of Refractory Chronic Lymphocytic Leukemia
Nikitin EA, Dmitrieva EA, Panteleev MA, Emelina EI, Ivanova VL, Kochkareva YuB, Arshanskaya EG, Lazarev IE, Markova EE, Mukha LA, Novitskaya NG, Pankrashkina MM, Glazunova VV, Shubina AV, Chernysh SА, Khuazheva NK, Naumova EV, Lugovskaya SA, Pochtar’ ME, Obukhova TN, Vinogradova OYu, Gendlin GE, Ptushkin VV |
|
| Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia
Interview with E.A. Nikitin |
|
| New Medications for Chronic Lymphocytic Leukemia
Interview with Jan Burger |
|
|
CLINICAL GUIDELINES |
|
| Clinical Recommendations for the Diagnosis and Treatment of Chronic Myeloid Leukemia
Turkina AG, Zaritskii AYu, Shuvaev VA, Chelysheva EYu, Lomaia EG, Morozova EV, Golenkov AK, Pospelova TI, Shukhov OA, Fominykh MS, Gusarova GA, Kuz’mina LA, Abdullaev AO, Martynkevich IS |
|
|
REVIEWS |
|
| Cytogenetic and Molecular Genetic Prognostic Factors of Acute Lymphoblastic Leukemias
Misyurin AV |
|
| Pathological Metabolism of Methionine in Malignant Cells Is a Potential Target for the Antitumor Therapy
Pokrovskii VS, Davydov DZh, Anufrieva NV, Zhdanov DD, Treshchalina EM, Demidkina TV, Morozova EA |
|
|
RARE HEMATOLOGICAL TUMORS AND SYNDROMES |
|
| The Clinical Manifestation and Errors in the Diagnosis of Classical Paroxysmal Nocturnal Hemoglobinuria: A clinical case series of 150 patients
Kulagin AD, Klimova OU, Dobronravov AV, Ivanova MO, Rudakova TA, Babenko EV, Dobronravov VA, Afanas’ev BV |
|
|
BONE MARROW TRANSPLANTATION |
|
| Acute Lymphoblastic Leukemia with t(4;11)(q21;q23)/KMT2A-AFF1 Translocation: The Results of Allogeneic Hematopoietic Stem Cells Transplantation in Children and Adults
Gindina TL, Mamaev NN, Paina OV, Borovkova AS, Kozhokar’ PV, Slesarchuk OA, Gudozhnikova YaV, Darskaya EI, Alyanskii AL, Bondarenko SN, Zubarovskaya LS, Afanas’ev BV |
|
| The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Ovechkina VN, Bondarenko SN, Morozova EV, Moiseev IS, Osipova AA, Gindina TL, Shakirova AI, Bykova TA, Kulagin AD, Samorodova IA, Karyakina EV, Ukrainchenko EA, Zubarovskaya LS, Afanas’ev BV |
|
|
LYMPHOID TUMORS |
|
| The IVDG Regimen is the Possible Treatment of Choice as First Line Therapy For Hodgkin’s Lymphoma in Elderly Patients with Cardiovascular and Pulmonary Comorbidity
Kaplanov KD, Klitochenko TYu, Shipaeva АL, Shirokova MN, Matveeva IV, Lavrishina NB |
|
| The Treatment of Drug-Resistant Fungoides Mycosis and Sezary Syndrome
Gorenkova LG, Penskaya EA, Kravchenko SK, Kovrigina AM, Moiseeva TN, Vorob’ev AI |
|
| Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma
Petrov AV, Motorin DV, Pokrovskaya OS, Urnova ES, Nareiko MV, Babenetskaya DV, Alekseeva YuA, Girshova LL, Mendeleeva LP, Zaritskii AYu |
|
| Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children
Batmanova NА, Shervashidze MА, Popa АV, Grivtsova LYu, Serebryakova IN, Мentkevich GL |
|
|
MYELOID TUMORS |
|
| Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice
Turkina AG, Novitskaya NV, Golenkov AK, Shuvaev VA, Napso LI, Krylova IV, Savrilova AM, Safuanova GSh, Korobkin AV, Klitochenko TYu, Burnasheva EV, Vasil’ev EV, Senderova OM, Fedorova EYu, Yalunina LM, Nekhai EK, Kuchma GB, Lyamkina AS, Shchedrova NG |
|
| Molecular Genetic Markers and Clinical Characteristics of Essential Thrombocythemia
Zhernyakova AA, Martynkevich IS, Shuvaev VA, Polushkina LB, Fominykh MS, Udal’eva VYu, Zotova II, Shikhbabaeva DI, Zenina MN, Potikhonova NA, Voloshin SV, Bessmel’tsev SS, Chechetkin AV, Abdulkadyrov KM |
|
|
HEMOSTASIS |
|
| Thrombophilia and Pregnancy
Galaiko MV, Rybina OV, Litvinenko MS, Klimov YuV, Al’tshuler BYu, Gubkin AV |
|
